References
- Weitz JI, Harenberg J. New developments in anticoagulants: past, present and future. Thromb Haemost. 2017;117(7):1283–1288.
- Steffel J, Luscher TF. Vitamin K antagonists. Ready to be replaced? Hamostaseologie. 2012;32(4):249–257.
- Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330–1393.
- Salmonson T, Dogné JM, Janssen H, et al. Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: views from a workshop at the European Medicines Agency (EMA). Eur Heart J Cardiovasc Pharmacother. 2017;3(1):42–47.
- Gosselin RC, Adcock DM, Bates SM, et al. International Council for Standardization in Haematology (ICSH) Recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost. 2018;118(3):437–450.
- Gous T, Couchman L, Patel JP, et al. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry. Ther Drug Monit. 2014;36(5):597–605.
- McGrail R, Revsholm J, Nissen PH, et al. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment. Thromb Res. 2016;148:107–110.
- Boissier E, Genebrier S, Lakhal K, et al. Rivaroxaban and apixaban anti-Xa measurements: Impact of plasma storage for 7 days at room temperature. Thromb Haemost. 2018;118(8):1488–1490.
- Cornes M, Simundic AM, Cadamuro J, et al. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2020;59(1):59–69.
- Clinical and Laboratory Standards Institute. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. CLSI document H21-A5. Wayne (PA): CLSI; 2008.
- Clinical and Laboratory Standards Institute. Evaluation of precision performance of clinical chemistry devices; approved guideline. CLSI document EP5-A. Wayne (PA): CLSI; 1999.
- ISO 5725-6. Accuracy (trueness and precision) of measurement methods and results. Part 6: use in practice of accuracy values. 1994.
- Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem. 2012;45(6):464–469.
- Sandberg S, Fraser CG, Horvath AR, et al. Defining analytical performance specifications: consensus statement from the 1st strategic conference of the european federation of clinical chemistry and laboratory medicine. Clin Chem Lab Med. 2015;53(6):833–835.